The scientific community reacted to the COVID-19 pandemic with unprecedented speed and cooperation. Grounded in experience with global health threats such as HIV as well as the impact of infectious diseases on cancer patients, Fred Hutch Cancer Center researchers played an important part in the international scientific response to the pandemic. They’ve worked tirelessly — tracking and modeling the virus' spread, detailing the immune response to the virus, conducting trials of vaccines and treatments, and working to prevent future outbreaks.

Fred Hutch Expertise During COVID-19 Pandemic

Tracking a New Threat

When the World Health Organization gave names to COVID-19 and SARS-CoV-2, the virus that causes it, in February 2020, Fred Hutch scientists had already been tracking the novel coronavirus and working to understand, predict and prepare for what might be ahead.

COVID-19 Clinical Research Center

By fall 2020, Fred Hutch opened our newly renovated COVID-19 Clinical Research Center, one of the first stand-alone centers specifically designed to test novel interventions such as monoclonal antibodies and antivirals to treat and prevent COVID-19.

Vaccine Leadership

The first COVID-19 vaccines received approval after being developed and trialed at a historic pace, thanks to the Fred Hutch-led COVID-19 Prevention Network, funded by the National Institute of Allergy and Infectious Diseases.

COVID-19 Research

Our virologists, as well as many of our cancer and basic science researchers, were deeply involved in a wide range of pandemic-related studies throughout the early to mid-2020s. At one point, as many as 20% of Fred Hutch researchers had active projects focused on COVID-19 and SARS-CoV-2.

Along with research to conceive of, develop and test COVID-19 vaccines and treatments, Fred Hutch:

Looking Ahead

As COVID-19 has transformed from a fast-growing pandemic to a more stable, endemic disease, Fred Hutch remains at the forefront of efforts to track and understand it, protect communities from infection and learn lessons to keep us all safer when the next new pandemic emerges.

Fred Hutch researchers have invented new tools to analyze the enormous dataset of genomic sequences of SARS-CoV-2 and its many variants , and we’re involved in research on next-generation COVID-19 vaccines, identifying ways to confirm if vaccines taken as a pill or nasal spray will be effective.

Latest COVID-19 News

All news
Nextstrain virus-tracking platform moves into new phase Dr. JT McCrone will oversee Gates Foundation-funded efforts to further empower users July 27, 2026
Dr. Elizabeth Halloran, expert in vaccine trial design and quantitative methods for infectious diseases, transitions to emerita Infectious disease modeling pioneer helped outline modern precepts for design and analysis of vaccine trials, causal inference with interference; shaped a generation of infectious disease scientists January 30, 2026
Managing mountains of genomic data Tools invented at Fred Hutch are helping researchers analyze the enormous global database of genomic sequences of the virus that causes COVID-19 to better understand how pathogens evolve and spread April 22, 2025
Drs. Keith Jerome and Jesse Bloom elected fellows of American Academy of Microbiology Fred Hutch researchers’ study of viruses evolves from basic understanding to practical applications March 20, 2025

Support COVID-19 Research

Every dollar helps our scientists reduce the threat of the novel coronavirus.